THE AMERICAN EDIT

head and neck cancer

The latest reporting, guides and features on head and neck cancer.

FDA entrance sign in front of Building 21 at the White Oak campus

FDA approves Rybrevant Faspro for some adults with head and neck cancer

The accelerated approval covers a specific group of adults after chemotherapy and immunotherapy. Here is what the study showed and what remains open.

November 5, 2026 · 3 min read